Abnormalities, Drug-Induced
"Abnormalities, Drug-Induced" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
Concept/Terms
Abnormalities, Drug-Induced- Abnormalities, Drug-Induced
- Abnormalities, Drug Induced
- Drug-Induced Abnormalities
- Abnormality, Drug-Induced
- Drug Induced Abnormalities
- Drug-Induced Abnormality
Below are MeSH descriptors whose meaning is more general than "Abnormalities, Drug-Induced".
Below are MeSH descriptors whose meaning is more specific than "Abnormalities, Drug-Induced".
This graph shows the total number of publications written about "Abnormalities, Drug-Induced" by people in Harvard Catalyst Profiles by year, and whether "Abnormalities, Drug-Induced" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 6 | 1 | 7 |
| 1995 | 0 | 1 | 1 |
| 1997 | 2 | 3 | 5 |
| 1998 | 2 | 0 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 3 | 4 | 7 |
| 2001 | 5 | 3 | 8 |
| 2002 | 4 | 2 | 6 |
| 2003 | 3 | 1 | 4 |
| 2004 | 3 | 3 | 6 |
| 2005 | 5 | 0 | 5 |
| 2006 | 2 | 2 | 4 |
| 2007 | 8 | 2 | 10 |
| 2008 | 2 | 2 | 4 |
| 2009 | 5 | 3 | 8 |
| 2010 | 5 | 1 | 6 |
| 2011 | 6 | 1 | 7 |
| 2012 | 7 | 1 | 8 |
| 2013 | 4 | 1 | 5 |
| 2014 | 3 | 0 | 3 |
| 2015 | 7 | 1 | 8 |
| 2016 | 5 | 0 | 5 |
| 2017 | 6 | 4 | 10 |
| 2018 | 7 | 1 | 8 |
| 2019 | 2 | 4 | 6 |
| 2020 | 7 | 5 | 12 |
| 2021 | 3 | 0 | 3 |
| 2022 | 3 | 0 | 3 |
| 2023 | 3 | 0 | 3 |
Below are the most recent publications written about "Abnormalities, Drug-Induced" by people in Profiles.
-
Risk of Major Malformations Following First-Trimester Exposure to Olanzapine: Preliminary Data From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications. J Clin Psychopharmacol. 2023 Mar-Apr 01; 43(2):106-112.
-
Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US. JAMA Psychiatry. 2023 02 01; 80(2):156-166.
-
Atomoxetine in Early Pregnancy and the Prevalence of Major Congenital Malformations: A Multinational Study. J Clin Psychiatry. 2023 01 16; 84(1).
-
Pregnancy outcomes after first-trimester exposure to buspirone: prospective longitudinal outcomes from the MGH National Pregnancy Registry for Psychiatric Medications. Arch Womens Ment Health. 2022 10; 25(5):923-928.
-
The North American Antiepileptic Drug Pregnancy Registry: A Canadian Subgroup Analysis. Can J Neurol Sci. 2023 03; 50(2):214-220.
-
Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies. Am J Obstet Gynecol. 2022 08; 227(2):263.e1-263.e38.
-
Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. J Clin Psychiatry. 2021 08 03; 82(4).
-
Active Surveillance of the Safety of Medications Used During Pregnancy. Am J Epidemiol. 2021 06 01; 190(6):1159-1168.
-
Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort study. BMJ. 2021 02 10; 372:n102.
-
The Association Between Antidepressant Exposure and Birth Defects-Are We There Yet? JAMA Psychiatry. 2020 12 01; 77(12):1215-1216.